USD 79.59
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| HSIC | 4.6 | 7.1 | 13.0 | 13.1 | 11.4 | 5.8 | 5.7 | 13.0 | 45.0 | 1684.2 |
| S&P 500 | -0.4 | -1.2 | 1.3 | 3.6 | 10.7 | 22.7 | 33.9 | 84.7 | 199.1 | 34133.5 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | HSIC |
| name | Henry Schein, Inc. |
| price | 79.59 |
| changes percentage | 4.5861 |
| change | 3.49 |
| day low | 77.6 |
| day high | 81.8528 |
| year high | 82.63 |
| year low | 63.67 |
| market cap | 9923360790 |
| price avg 50 | 72.8792 |
| price avg 200 | 70.57885 |
| exchange | NASDAQ |
| volume | 3565630 |
| avg volume | 1528848 |
| open | 78 |
| previous close | 76.1 |
| eps | 2.44 |
| pe | 32.62 |
| earnings announcement | 2025-02-25T13:30:00.000+0000 |
| shares outstanding | 124681000 |
| timestamp | 2025-01-29 20:36:32 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001000228 | |||
| revenue | 12339000000 | 12647000000 | -2.44 |
| gross profit | 3861000000 | 3831000000 | 0.78 |
| gross profit ratio | 0.31 | 0.3 | 3.30 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 3246000000 | 2953000000 | 9.92 |
| interest income | 17000000 | 17000000 | 0.00 |
| interest expense | 87000000 | 44000000 | 97.73 |
| ebitda | 877000000 | 1090000000 | -19.54 |
| ebitdaratio | 0.07 | 0.09 | -18.87 |
| operating income | 615000000 | 747000000 | -17.67 |
| operating income ratio | 0.05 | 0.06 | -15.62 |
| net income | 416000000 | 538000000 | -22.68 |
| net income ratio | 0.03 | 0.04 | -20.75 |
| eps | 3.18 | 3.95 | -19.49 |
Revenue Growth: revenue decreased to 12,339 million in 2023 from 12,647 million in 2022 representing a change of -2.44%. This indicates a sales shrinking, which is a negative sign for the company.
Operating Expenses: Operating Expenses increased to 3,246 million in 2023 from 2,953 million in 2022 representing a change of 9.92%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Operating Income: Operating income decreased to 615 million in 2023 from 747 million in 2022 representing a change of -17.67%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 416 million in 2023 from 538 million in 2022 representing a change of -22.68%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 3.18 in 2023 from 3.18 in 2022 representing a change of -19.49%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Gross Profit: Gross Profit increased to 3,861 million in 2023 from 3,831 million in 2022 representing a change of 0.78%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 877 million in 2023 from 1,090 million in 2022 representing a change of -19.54%. The increase in EBITDA indicates improved operational efficiency and profitability.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001000228 | |||
| revenue | 3174000000 | 3136000000 | 1.21 |
| gross profit | 993000000 | 955000000 | 3.98 |
| gross profit ratio | 0.31 | 0.3 | 2.73 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 836000000 | 781000000 | 7.04 |
| interest income | 7000000 | 6000000 | 16.67 |
| interest expense | 34000000 | 32000000 | 6.25 |
| ebitda | 236000000 | 252000000 | -6.35 |
| ebitdaratio | 0.07 | 0.08 | -5.98 |
| operating income | 157000000 | 174000000 | -9.77 |
| operating income ratio | 0.05 | 0.06 | -10.85 |
| net income | 99000000 | 104000000 | -4.81 |
| net income ratio | 0.03 | 0.03 | -5.95 |
| eps | 0.78 | 0.81 | -3.70 |
Revenue Growth: revenue increased to 3,174 million in 2024Q3 from 3,136 million in 2024Q2 representing a change of 1.21%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 993 million in 2024Q3 from 955 million in 2024Q2 representing a change of 3.98%. This indicates a sales profitability growth, which is a positive sign for the company.
Net Income: Net income increased to 99 million in 2024Q3 from 104 million in 2024Q2 representing a change of -4.81%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Operating Expenses: Operating Expenses increased to 836 million in 2024Q3 from 781 million in 2024Q2 representing a change of 7.04%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 236 million in 2024Q3 from 252 million in 2024Q2 representing a change of -6.35%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 157 million in 2024Q3 from 174 million in 2024Q2 representing a change of -9.77%. The decrease in operating income indicates worse operational performance and decreased profitability.
Earnings per Share (EPS): EPS increased to 0.78 in 2024Q3 from 0.78 in 2024Q2 representing a change of -3.7%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001000228 | |||
| total assets | 10573000000 | 8607000000 | 22.84 |
| total liabilities | 5420000000 | 3936000000 | 37.70 |
| total equity | 5153000000 | 4671000000 | 10.32 |
| cash and cash equivalents | 171000000 | 117000000 | 46.15 |
| short term investments | 0 | 0 | NaN |
| long term investments | 224000000 | 161000000 | 39.13 |
| total current assets | 4488000000 | 3988000000 | 12.54 |
| total non current assets | 6085000000 | 4619000000 | 31.74 |
| total current liabilities | 2683000000 | 2224000000 | 20.64 |
| total non current liabilities | 2737000000 | 1712000000 | 59.87 |
| common stock | 1000000 | 1000000 | 0.00 |
| retained earnings | 3860000000 | 3678000000 | 4.95 |
| total debt | 2741000000 | 1497000000 | 83.10 |
Total Assets: Total Assets increased to 10,573 million in 2023 from 8,607 million in 2022 representing a change of 22.84%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 5,153 million in 2023 from 4,671 million in 2022 representing a change of 10.32%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 171 million in 2023 from 117 million in 2022 representing a change of 46.15%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 4,488 million in 2023 from 3,988 million in 2022 representing a change of 12.54%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to 3,860 million in 2023 from 3,678 million in 2022 representing a change of 4.95%. This indicates an accumulated profits.
Total Liabilities: Total Liabilities increased to 5,420 million in 2023 from 3,936 million in 2022 representing a change of 37.7%. This indicates an increase in overall liabilities.
Total Current Liabilities: Total Current Liabilities increased to 2,683 million in 2023 from 2,224 million in 2022 representing a change of 20.64%. This indicates a higher short-term debt burden.
Total Debt: Total Debt increased to 2,741 million in 2023 from 1,497 million in 2022 representing a change of 83.1%. This indicates an increase in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001000228 | |||
| total assets | 10605000000 | 10251000000 | 3.45 |
| total liabilities | 5634000000 | 5247000000 | 7.38 |
| total equity | 4971000000 | 5004000000 | -0.66 |
| cash and cash equivalents | 126000000 | 138000000 | -8.70 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 502000000 | -100.00 |
| total current assets | 4147000000 | 3941000000 | 5.23 |
| total non current assets | 6458000000 | 6310000000 | 2.35 |
| total current liabilities | 2929000000 | 2549000000 | 14.91 |
| total non current liabilities | 2705000000 | 2698000000 | 0.26 |
| common stock | 1000000 | 1000000 | 0.00 |
| retained earnings | 3766000000 | 3803000000 | -0.97 |
| total debt | 2992000000 | 2838000000 | 5.43 |
Total Assets: Total Assets increased to 10,605 million in 2024Q3 from 10,251 million in 2024Q2 representing a change of 3.45%. Suggesting a growth in asset holdings.
Total Current Assets: Total Current Assets increased to 4,147 million in 2024Q3 from 3,941 million in 2024Q2 representing a change of 5.23%. This indicates a better liquidity position.
Total Liabilities: Total Liabilities increased to 5,634 million in 2024Q3 from 5,247 million in 2024Q2 representing a change of 7.38%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 4,971 million in 2024Q3 from 5,004 million in 2024Q2 representing a change of -0.66%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 126 million in 2024Q3 from 138 million in 2024Q2 representing a change of -8.7%. This indicates a decrease in available liquid assets.
Total Current Liabilities: Total Current Liabilities increased to 2,929 million in 2024Q3 from 2,549 million in 2024Q2 representing a change of 14.91%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to 3,766 million in 2024Q3 from 3,803 million in 2024Q2 representing a change of -0.97%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 2,992 million in 2024Q3 from 2,838 million in 2024Q2 representing a change of 5.43%. This indicates an increase in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001000228 | |||
| net change in cash | 54000000 | -1000000 | 5500.00 |
| operating cash flow | 500000000 | 602000000 | -16.94 |
| free cash flow | 313000000 | 506000000 | -38.14 |
| capital expenditure | -187000000 | -96000000 | -94.79 |
| depreciation and amortization | 248000000 | 212000000 | 16.98 |
| deferred income tax | -20000000 | -61000000 | 67.21 |
| stock based compensation | 39000000 | 54000000 | -27.78 |
| accounts payables | -56000000 | -96000000 | 41.67 |
| inventory | 231000000 | -126000000 | 283.33 |
| acquisitions net | -974000000 | -158000000 | -516.46 |
| investments in property plant and equipment | -147000000 | -96000000 | -53.12 |
| net cash used for investing activites | -1135000000 | -276000000 | -311.23 |
| debt repayment | 1053000000 | 211000000 | 399.05 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -250000000 | -485000000 | 48.45 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 701000000 | -315000000 | 322.54 |
| cash at end of period | 171000000 | 117000000 | 46.15 |
| accounts receivables | -327000000 | -7000000 | -4571.43 |
| cash at beginning of period | 117000000 | 118000000 | -0.85 |
Net Change in Cash: Net Change in Cash increased to 54 million in 2023 from -1 million in 2022 representing a change of 5500.0%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Capital Expenditure: Capital Expenditure decreased to -187 million in 2023 from -96 million in 2022 representing a change of -94.79%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 39 million in 2023 from 54 million in 2022 representing a change of -27.78%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 56 million in 2023 from 96 million in 2022 representing a change of 41.67%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to -327 million in 2023 from -7 million in 2022 representing a change of -4571.43%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Operating Cash Flow: Operating Cash Flow decreased to 500 million in 2023 from 602 million in 2022 representing a change of -16.94%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to 313 million in 2023 from 506 million in 2022 representing a change of -38.14%. This indicates a decrease in cash generated after accounting for capital expenditures.
Deferred Income Tax: Deferred Income Tax increased to -20 million in 2023 from -61 million in 2022 representing a change of 67.21%. This indicates that the company's tax liability for future periods has increased.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001000228 | |||
| operating cash flow | 151000000 | 296000000 | -48.99 |
| free cash flow | 117000000 | 248000000 | -52.82 |
| capital expenditure | -34000000 | -48000000 | 29.17 |
| depreciation and amortization | 74000000 | 74000000 | 0.00 |
| deferred income tax | -22000000 | -21000000 | -4.76 |
| stock based compensation | 0 | 12000000 | -100.00 |
| accounts receivables | -82000000 | 80000000 | -202.50 |
| accounts payables | 161000000 | -2000000 | 8150.00 |
| inventory | -69000000 | 33000000 | -309.09 |
| acquisitions net | -86000000 | -278000000 | 69.06 |
| investments in property plant and equipment | -44000000 | -48000000 | 8.33 |
| net cash used for investing activites | -135000000 | -326000000 | 58.59 |
| debt repayment | 146000000 | 125000000 | 16.80 |
| common stock issued | 1000000 | 0 | NaN |
| common stock repurchased | -135000000 | -100000000 | -35.00 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 3000000 | 3000000 | 0.00 |
| net change in cash | -12000000 | -21000000 | 42.86 |
| cash at end of period | 126000000 | 138000000 | -8.70 |
| cash at beginning of period | 138000000 | 159000000 | -13.21 |
Net Change in Cash: Net Change in Cash increased to -12 million in 2024Q3 from -21 million in 2024Q2 representing a change of 42.86%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q3 from 12 million in 2024Q2 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Receivables: Accounts Receivables decreased to -82 million in 2024Q3 from 80 million in 2024Q2 representing a change of -202.5%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Operating Cash Flow: Operating Cash Flow decreased to 151 million in 2024Q3 from 296 million in 2024Q2 representing a change of -48.99%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to 117 million in 2024Q3 from 248 million in 2024Q2 representing a change of -52.82%. This indicates a decrease in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure increased to -34 million in 2024Q3 from -48 million in 2024Q2 representing a change of 29.17%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Accounts Payables: The absolute value of Accounts Payables increased to 161 million in 2024Q3 from 2 million in 2024Q2 representing a change of 8150.0%. This indicates that the company has increased its outstanding obligations to its suppliers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-30 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 94.47 | 92.95 | 1.63 |
| net income per share | 3.18 | 3.95 | -19.45 |
| operating cash flow per share | 3.83 | 4.42 | -13.48 |
| free cash flow per share | 2.4 | 3.72 | -35.56 |
| cash per share | 1.31 | 0.86 | 52.25 |
| book value per share | 39.45 | 34.33 | 14.92 |
| tangible book value per share | 2.77 | 8.75 | -68.34 |
| shareholders equity per share | 27.98 | 25.33 | 10.49 |
| interest debt per share | 21.65 | 11.33 | 91.17 |
| market cap | 9889163732.9 | 10867449331.27 | -9.00 |
| enterprise value | 12459163732.9 | 12247449331.27 | 1.73 |
| pe ratio | 23.77 | 20.2 | 17.68 |
| price to sales ratio | 0.8 | 0.86 | -6.73 |
| pocfratio | 19.78 | 18.05 | 9.56 |
| pfcf ratio | 31.59 | 21.48 | 47.11 |
| pb ratio | 2.71 | 3.15 | -14.21 |
| ptb ratio | 2.71 | 3.15 | -14.21 |
| ev to sales | 1.01 | 0.97 | 4.27 |
| enterprise value over ebitda | 14.21 | 11.24 | 26.44 |
| ev to operating cash flow | 24.92 | 20.34 | 22.48 |
| ev to free cash flow | 39.81 | 24.2 | 64.46 |
| earnings yield | 0.04 | 0.05 | -15.03 |
| free cash flow yield | 0.03 | 0.05 | -32.02 |
| debt to equity | 0.75 | 0.43 | 72.63 |
| debt to assets | 0.26 | 0.17 | 49.05 |
| net debt to ebitda | 2.93 | 1.27 | 131.46 |
| current ratio | 1.67 | 1.79 | -6.72 |
| interest coverage | 7.07 | 16.98 | -58.36 |
| income quality | 1.2 | 1.06 | 13.00 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.45 | 0.4 | 12.07 |
| capex to operating cash flow | 0.37 | 0.16 | 134.53 |
| capex to revenue | 0.02 | 0.01 | 99.65 |
| capex to depreciation | 0.75 | 0.45 | 66.52 |
| stock based compensation to revenue | 0.0 | 0.0 | -25.98 |
| graham number | 44.78 | 47.47 | -5.66 |
| roic | 0.06 | 0.09 | -34.39 |
| return on tangible assets | 0.07 | 0.1 | -31.44 |
| graham net net | -22.54 | -12.91 | -74.66 |
| working capital | 1805000000 | 1764000000 | 2.32 |
| tangible asset value | 362000000 | 1191000000 | -69.61 |
| net current asset value | -932000000 | 52000000 | -1892.31 |
| invested capital | 7419000000 | 5911000000 | 25.51 |
| average receivables | 1652500000 | 1446914500 | 14.21 |
| average payables | 1012000000 | 1028967000 | -1.65 |
| average inventory | 1889000000 | 1912069000 | -1.21 |
| days sales outstanding | 55.11 | 41.62 | 32.42 |
| days payables outstanding | 43.91 | 41.57 | 5.64 |
| days of inventory on hand | 78.14 | 81.27 | -3.85 |
| receivables turnover | 6.62 | 8.77 | -24.48 |
| payables turnover | 8.31 | 8.78 | -5.34 |
| inventory turnover | 4.67 | 4.49 | 4.01 |
| roe | 0.11 | 0.16 | -27.10 |
| capex per share | 1.43 | 0.71 | 102.91 |
ROE:
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 23.77 on 2023-12-30 from 20.20 on 2022-12-31, representing a change of 17.68%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 1.67 on 2023-12-30 from 1.79 on 2022-12-31, representing a change of -6.72%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.75 on 2023-12-30 from 0.43 on 2022-12-31, representing a change of 72.63%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-28 Q3 | 2024-06-29 Q2 | Q/Q change % | |
|---|---|---|---|
| HSIC | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 25.17 | 24.54 | 2.54 |
| net income per share | 0.78 | 0.81 | -3.56 |
| operating cash flow per share | 1.2 | 2.32 | -48.32 |
| free cash flow per share | 0.93 | 1.94 | -52.20 |
| cash per share | 1.0 | 1.08 | -7.49 |
| book value per share | 39.41 | 39.16 | 0.65 |
| tangible book value per share | -0.91 | 0.14 | -747.30 |
| shareholders equity per share | 27.77 | 27.48 | 1.06 |
| interest debt per share | 23.99 | 22.46 | 6.82 |
| market cap | 9234851632.3 | 8190978758.0 | 12.74 |
| enterprise value | 12100851632.3 | 10890978758 | 11.11 |
| pe ratio | 23.32 | 19.69 | 18.44 |
| price to sales ratio | 2.91 | 2.61 | 11.39 |
| pocfratio | 61.16 | 27.67 | 121.01 |
| pfcf ratio | 78.93 | 33.03 | 138.98 |
| pb ratio | 2.64 | 2.33 | 13.03 |
| ptb ratio | 2.64 | 2.33 | 13.03 |
| ev to sales | 3.81 | 3.47 | 9.78 |
| enterprise value over ebitda | 51.27 | 43.22 | 18.64 |
| ev to operating cash flow | 80.14 | 36.79 | 117.80 |
| ev to free cash flow | 103.43 | 43.92 | 135.51 |
| earnings yield | 0.01 | 0.01 | -15.57 |
| free cash flow yield | 0.01 | 0.03 | -58.16 |
| debt to equity | 0.85 | 0.81 | 5.70 |
| debt to assets | 0.28 | 0.28 | 1.91 |
| net debt to ebitda | 12.14 | 10.71 | 13.34 |
| current ratio | 1.42 | 1.55 | -8.42 |
| interest coverage | 4.62 | 5.44 | -15.08 |
| income quality | 1.53 | 2.85 | -46.41 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.48 | 0.49 | -1.40 |
| capex to operating cash flow | 0.23 | 0.16 | 38.85 |
| capex to revenue | 0.01 | 0.02 | -30.01 |
| capex to depreciation | 0.46 | 0.65 | -29.17 |
| stock based compensation to revenue | 0 | 0.0 | -100.00 |
| graham number | 22.15 | 22.43 | -1.28 |
| roic | 0.01 | 0.02 | -10.96 |
| return on tangible assets | 0.02 | 0.02 | -9.19 |
| graham net net | -26.85 | -24.35 | -10.26 |
| working capital | 1218000000 | 1392000000 | -12.50 |
| tangible asset value | -115000000 | 18000000 | -738.89 |
| net current asset value | -1487000000 | -1306000000 | -13.86 |
| invested capital | 7148000000 | 7200000000 | -0.72 |
| average receivables | 1609500000 | 1601500000 | 0.50 |
| average payables | 946500000 | 873000000 | 8.42 |
| average inventory | 1705500000 | 1671500000 | 2.03 |
| days sales outstanding | 47.07 | 44.74 | 5.20 |
| days payables outstanding | 42.34 | 35.78 | 18.34 |
| days of inventory on hand | 72.38 | 68.38 | 5.85 |
| receivables turnover | 1.91 | 2.01 | -4.95 |
| payables turnover | 2.13 | 2.52 | -15.50 |
| inventory turnover | 1.24 | 1.32 | -5.53 |
| roe | 0.03 | 0.03 | -4.56 |
| capex per share | 0.27 | 0.38 | -28.23 |
ROE: Return on Equity (ROE) decreased to 0.03 on 2024-09-28 Q3 from 0.03 on 2024-06-29 Q2, representing a change of -4.56%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 23.32 on 2024-09-28 Q3 from 19.69 on 2024-06-29 Q2, representing a change of 18.44%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 1.42 on 2024-09-28 Q3 from 1.55 on 2024-06-29 Q2, representing a change of -8.42%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.85 on 2024-09-28 Q3 from 0.81 on 2024-06-29 Q2, representing a change of 5.70%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Negative Sentiment: Discounted Cash Flow value is 76.57 which is lower than current price 79.55, indicates the company may be overvalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-29 05:45:26
Private-equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of healthcare products to improve its operations, the Wall Street Journal reported on Wednesday citing people familiar with the matter.
Sentiment: Neutral
Publish Date: 2025-01-23 06:30:00
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to webcast fourth quarter and full-year 2024 conference call on February 25, 2025.
Sentiment: Negative
Publish Date: 2025-01-22 16:37:42
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein , arguing the dental and medical distributor needs to start searching for a new CEO, cut costs and optimize capital allocation, three sources familiar with the matter said.
Sentiment: Positive
Publish Date: 2025-01-16 08:31:15
Henry Schein completes the acquisition of Acentus, which expands the former's Home Solution business.
Sentiment: Positive
Publish Date: 2025-01-16 06:42:00
BOSTON and NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Acentus in the acquisition of substantially all of its assets by Henry Schein, Inc. Acentus is a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, bringing their expertise and experience in the product category and the healthcare industry.
Sentiment: Neutral
Publish Date: 2025-01-15 06:30:00
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein completes acquisition of Acentus.
Sentiment: Positive
Publish Date: 2025-01-14 09:25:00
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the opening of the Henry Schein Cares Foundation 2025 Relief Fund to support the Los Angeles area fires. Contributions will support the provision of critical health care supplies and resources to help people impacted by the wildfires throughout the city. The Company and Henry Schein Cares Foundation will donate an initial $25,000 each to support relief efforts and the Company will match Team Schein Member (TSM) c.
Sentiment: Negative
Publish Date: 2025-01-09 06:30:00
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers throughout California that the Henry Schein Customer Emergency Support Hotline is open for dental and medical professionals who may experience operational, logistical, or financial issues as a result of damage caused by the ongoing fires. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 8 a.m. to.
Sentiment: Positive
Publish Date: 2025-01-02 11:31:09
Henry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating efficiency.
Sentiment: Positive
Publish Date: 2024-12-19 08:26:07
Investors are optimistic about HSIC owing to the performance of its dental business.
Sentiment: Neutral
Publish Date: 2024-12-17 06:30:00
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to participate at J.P. Morgan's Healthcare Investor Conference.
Sentiment: Positive
Publish Date: 2024-12-13 10:41:16
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sentiment: Neutral
Publish Date: 2024-12-05 12:35:41
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Sentiment: Positive
Publish Date: 2024-11-26 10:40:59
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Sentiment: Positive
Publish Date: 2024-11-23 07:47:51
Ananym Capital is calling for changes at Henry Schein, which may help the company improve its profitability.
Sentiment: Positive
Publish Date: 2024-11-21 09:50:34
Henry Schein inked a new agreement to acquire Acentus to enhance its ability to deliver CGM products directly to patients' homes.
Sentiment: Neutral
Publish Date: 2024-11-21 06:30:00
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to participate in investor conferences in December.
Sentiment: Neutral
Publish Date: 2024-11-20 06:30:00
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to acquire Acentus, a leading supplier of homecare medical products.
Sentiment: Neutral
Publish Date: 2024-11-18 13:35:27
Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, sources close to matter said on Monday.
Sentiment: Positive
Publish Date: 2024-11-18 12:36:12
Henry Schein shares climbed more than 4% in Monday trading, on track to notch their best day since July. Financial firm Gordon Haskett said Robert F.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
